(Press-News.org) SAN DIEGO, April 4, 2014 – Genetic screening of cancer can help doctors customize treatments so that patients with melanoma have the best chance of beating it, according to the results of a clinical trial by researchers at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
The trial, funded by the National Institutes of Health (NIH), will be presented Monday at the American Association for Cancer Research (AACR) Annual Meeting 2014. It showed that the cancer immune therapy drug ipilimumab appears most likely to prevent recurrence in patients whose cancer shows high expression of immune-related genes.
"We've reached a point in the treatment of melanoma — and cancer in general — where we're making major improvements in the outcomes of patients through personalized medicine," said lead investigator Ahmad Tarhini, M.D., Ph.D., associate professor of medicine and translational science in Pitt's Department of Medicine and Clinical and Translational Science Institute. "Anti-cancer therapy can be associated with significant side effects and economic costs. Therefore, we have a major interest in the development of tests that may allow us to predict which treatment regimen is most likely to help certain patients, while sparing others the unwanted side effects and cost of medications that are unlikely to work."
Before and after ipilimumab treatment, Dr. Tarhini and his colleagues obtained tumor biopsies used to run genetic tests on the tumors of 32 patients with advanced, stage 3 melanoma who were treated by UPMC. All patients were given standard-of-care surgery, which included complete surgical removal of an advanced tumor.
Patients with tumors that had higher levels of expression of a group of immune-related genes, either before or soon after treatment with ipilimumab, had 63 percent lower risk of cancer recurrence after surgery.
"By validating these findings in a large national trial that also will allow us to investigate other significant biomarker data, we'll seek to develop 'biomarker signatures' that doctors can use to customize melanoma treatment plans. The ultimate goals of therapy are to best treat the cancer in an individualized approach, while avoiding the unnecessary exposure of patients to severe side effects," said Dr. Tarhini.
INFORMATION:
Additional researchers on this study are Yan Lin, Ph.D., Hui-Min Lin, M.S., Cindy Sander, B.S., William A. La Framboise, Ph.D., and John M. Kirkwood, M.D., all of UPCI.
This research was supported by NIH award P50CA121973 and Bristol-Myers Squibb.
About UPCI
As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. Investigators at UPCI, a partner with UPMC CancerCenter, are world-renowned for their work in clinical and basic cancer research.
http://www.upmc.com/media
Contact: Allison Hydzik
Phone: 412-647-9975
Mobile: 412-559-2431
E-mail: HydzikAM@upmc.edu
Contact: Jennifer Yates
Phone: 412-647-9966
E-mail: YatesJC@upmc.edu END
Genetic testing beneficial in melanoma treatment
2014-04-04
ELSE PRESS RELEASES FROM THIS DATE:
Combining cell replication blocker with common cancer drug kills resistant tumor cells
2014-04-04
SAN DIEGO, April 4, 2014 – Researchers from the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter, have found that an agent that inhibits mitochondrial division can overcome tumor cell resistance to a commonly used cancer drug, and that the combination of the two induces rapid and synergistic cell death. Separately, neither had an effect. These findings will be presented Monday at the annual meeting of the American Association for Cancer Research Annual Meeting 2014.
"In our earlier work, we found that blocking production of a protein called ...
International consortium discovers 2 genes that modulate risk of breast and ovarian cancer
2014-04-04
Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing from breast cancer before the age of 70. Taking critical decisions such as opting for preventive surgery when the risk bracket is so wide is not easy. Spanish National Cancer Research Centre (CNIO) researchers are conducting a study that will contribute towards giving every woman far more precise data about her personal risk of suffering from cancer.
The paper has been authored by 200 researchers from 55 research groups from around the world and describes two new genes ...
Screening reveals additional link between endometriosis and ovarian cancer
2014-04-04
SAN DIEGO, April 4, 2014 – Some women with endometriosis, a chronic inflammatory disease, are predisposed to ovarian cancer, and a genetic screening might someday help reveal which women are most at risk, according to a University of Pittsburgh Cancer Institute (UPCI) study, in partnership with Magee-Womens Research Institute (MWRI).
Monday at the American Association for Cancer Research (AACR) Annual Meeting 2014, UPCI and MWRI researchers will present the preliminary results of the first comprehensive immune gene profile exploring endometriosis and cancer.
"A small ...
Grandparents may worsen some moms' baby blues
2014-04-04
Does living with grandparents ease or worsen a mothers' baby blues? The answer may depend on the mother's marital status, a new study from Duke University suggests.
Married and single mothers suffer higher rates of depression when they live in multi-generational households in their baby's first year of life, the study found. But for moms who live with their romantic partners but aren't married, having one or more grandparents in the house is linked to lower rates of depression.
The pattern held true for rich, poor and middle class women. The findings varied by race, ...
Toward a clearer diagnosis of chronic fatigue syndrome
2014-04-04
Researchers at the RIKEN Center for Life Science Technologies, in collaboration with Osaka City University and Kansai University of Welfare Sciences, have used functional PET imaging to show that levels of neuroinflammation, or inflammation of the nervous system, are higher in patients with chronic fatigue syndrome than in healthy people.
Chronic fatigue syndrome, which is also known as myalgic encephalomyelitis, is a debilitating condition characterized by chronic, profound, and disabling fatigue. Unfortunately, the causes are not well understood.
Neuroinflammation ...
New study on the crime risk on London Underground
2014-04-04
A UNIVERSITY of Huddersfield criminologist who has been working closely with authorities in London to cut crime on one of the world's busiest transport systems will appear before a House of Commons select committee to describe his findings. Dr Andrew Newton is also forming links with overseas experts so that their research can make public transport systems around the world safer places to travel.
By analysing crime patterns on the London Underground, which carries more than one billion passengers a year, Dr Newton is able to draw conclusions about the environment of ...
New algorithm aids in both robot navigation and scene understanding
2014-04-04
Suppose you're trying to navigate an unfamiliar section of a big city, and you're using a particular cluster of skyscrapers as a reference point. Traffic and one-way streets force you to take some odd turns, and for a while you lose sight of your landmarks. When they reappear, in order to use them for navigation, you have to be able to identify them as the same buildings you were tracking before — as well as your orientation relative to them.
That type of re-identification is second nature for humans, but it's difficult for computers. At the IEEE Conference on Computer ...
Scientists unmask the climate uncertainty monster
2014-04-04
Scientific uncertainty has been described as a 'monster' that prevents understanding and delays mitigative action in response to climate change. New research by Professor Stephan Lewandowsky of the University of Bristol, and international colleagues, shows that uncertainty should make us more rather than less concerned about climate change.
In two companion papers, published today in Climatic Change, the researchers investigated the mathematics of uncertainty in the climate system and showed that increased scientific uncertainty necessitates even greater action to mitigate ...
Key genetic mutations could be new hope for adrenocortical tumor patients
2014-04-04
April 3, 2014, Shenzhen, China - Chinese researchers from Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, BGI, and other institutions have discovered that the activating hotspot L205R mutation in PRKACA gene was closely associated with adrenocortical tumors (ACTs), and the relationship of recurrently mutated DOT1L and CLASP2 with ACTs' other subtypes. The latest study published online in Science opens a new insight into diagnosis and treatment of Adrenal Cushing's syndrome.
Adrenal Cushing's syndrome results from autonomous production of cortisol ...
An ultrathin collagen matrix biomaterial tool for 3-D microtissue engineering
2014-04-04
A novel ultrathin collagen matrix assembly allows for the unprecedented maintenance of liver cell morphology and function in a microscale "organ-on-a-chip" device that is one example of 3D microtissue engineering.
A team of researchers from the Center for Engineering in Medicine at the Massachusetts General Hospital have demonstrated a new nanoscale matrix biomaterial assembly that can maintain liver cell morphology and function in microfluidic devices for longer times than has been previously been reported in microfluidic devices. This technology allows researchers to ...